- Advanced search
|International Nonproprietary Names|
|Search PubMed clinical trials||galcanezumab|
|Search PubMed titles||galcanezumab|
|Search PubMed titles/abstracts||galcanezumab|
|Galcanezumab (LY2951742) is an investigational monoclonal antibody targeting calcitonin A and B (CALCA a.k.a. α-CGRP and CALCB a.k.a. β-CGRP respectively), being investigated for its potential anti-migraine and analgesic actions.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Protein BLAST analysis reveals 100% matches with peptides claimed in patent WO2007076336 .